Skip to main content

UBS Group AG

Position in SGMT — Sagimet Biosciences Inc.

CIK 1610520 ZURICH, V8

Position in SGMT

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,535,804
+$341,392 QoQ
Shares Held
293,934
+45.7% QoQ
Ownership
0.476%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 38% Shared 0% None 62%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. SGMT ranks #225 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SGMT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,535,804 293,934
2025-12-31 $1,194,412 201,759
2025-09-30 $2,104,413 306,766
2025-06-30 $4,364,238 572,735
2025-03-31 $1,559,680 478,430
2024-12-31 $1,499,220 333,160
2024-09-30 $391,304 141,265
2024-06-30 $329,592 96,372
2024-03-31 $342,197 63,136
2023-12-31 $108,333 19,988
2023-09-30 $26,320 2,991